Biofrontera Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BFRI Nasdaq 2834 https://www.biofrontera-us.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biofrontera Inc

Biofrontera Inc. Makes Transformative Investment in Its' Dermatology Salesforce - Mar 27th, 2023 12:00 pm
Biofrontera Inc. to Attend 2023 American Academy of Dermatology Annual Meeting - Mar 17th, 2023 5:30 pm
Biofrontera Inc. (NASDAQ:BFRI) Analysts Just Slashed Next Year's Estimates - Mar 11th, 2023 12:50 pm
Biofrontera Inc. (NASDAQ:BFRI) Q4 2022 Earnings Call Transcript - Mar 10th, 2023 7:25 am
CORRECTING AND REPLACING: Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results - Mar 9th, 2023 1:20 pm
Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results - Mar 8th, 2023 9:03 pm
Biofrontera, Inc. to Present at the 35th Annual ROTH Conference on March 13, 2023 - Mar 2nd, 2023 2:00 pm
Biofrontera Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023 - Feb 22nd, 2023 1:00 pm
Biofrontera, Inc. to Present at Third Annual Winter Wonderland – Best Ideas Virtual Investor Conference on February 21st – 24th, 2023 - Feb 15th, 2023 1:00 pm
Breakeven On The Horizon For Biofrontera Inc. (NASDAQ:BFRI) - Jan 24th, 2023 3:27 pm
Biofrontera Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk - Jan 9th, 2023 6:00 pm
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2022 - Jan 9th, 2023 1:00 pm
Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of Stockholders - Dec 16th, 2022 1:30 pm
11 Best German Stocks to Buy Now - Dec 6th, 2022 3:18 pm
Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor Conference - Nov 30th, 2022 7:08 pm
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022 - Nov 28th, 2022 4:05 pm
Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk - Nov 21st, 2022 1:48 pm
Biofrontera Third Quarter 2022 Earnings: EPS Beats Expectations - Nov 16th, 2022 11:39 am
Biofrontera Inc. (BFRI) Reports Q3 Loss, Tops Revenue Estimates - Nov 14th, 2022 3:05 pm
Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update - Nov 14th, 2022 1:45 pm